Bridge Creek Capital Management LLC Grows Holdings in CVS Health Co. (NYSE:CVS)

Bridge Creek Capital Management LLC increased its stake in CVS Health Co. (NYSE:CVS) by 0.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,767 shares of the pharmacy operator’s stock after buying an additional 330 shares during the period. Bridge Creek Capital Management LLC’s holdings in CVS Health were worth $2,593,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Moody National Bank Trust Division grew its stake in CVS Health by 3.8% in the fourth quarter. Moody National Bank Trust Division now owns 24,185 shares of the pharmacy operator’s stock worth $1,086,000 after purchasing an additional 885 shares in the last quarter. Brookstone Capital Management grew its position in shares of CVS Health by 10.9% during the 4th quarter. Brookstone Capital Management now owns 69,420 shares of the pharmacy operator’s stock worth $3,116,000 after buying an additional 6,831 shares in the last quarter. Czech National Bank increased its stake in shares of CVS Health by 6.4% during the fourth quarter. Czech National Bank now owns 272,854 shares of the pharmacy operator’s stock valued at $12,248,000 after buying an additional 16,424 shares during the period. Graypoint LLC lifted its stake in CVS Health by 15.2% in the fourth quarter. Graypoint LLC now owns 5,187 shares of the pharmacy operator’s stock worth $233,000 after acquiring an additional 683 shares during the period. Finally, Ridgewood Investments LLC grew its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS Health stock traded up $3.43 during trading on Monday, reaching $51.44. The company had a trading volume of 17,978,866 shares, compared to its average volume of 14,000,489. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The firm’s 50-day simple moving average is $51.82 and its 200 day simple moving average is $56.55. The firm has a market capitalization of $64.73 billion, a PE ratio of 13.06, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the firm posted $2.21 EPS. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 5.17%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Analyst Ratings Changes

CVS has been the topic of several research reports. Royal Bank of Canada cut their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Truist Financial cut their price objective on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. UBS Group boosted their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Evercore ISI lifted their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $68.71.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.